Pulmonary Function Tests in Idiopathic Inflammatory Myopathy: Association With Clinical Parameters in Children

To determine the association of decreased lung function in children with idiopathic inflammatory myopathies (IIMs) with specific clinical parameters.

[1]  M. Labrador-Horrillo,et al.  Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays , 2012, Annals of the rheumatic diseases.

[2]  L. Pachman,et al.  Ovarian Teratoma Mimicking Features of Juvenile Dermatomyositis in a Child , 2011, Pediatrics.

[3]  L. Iaccarino,et al.  Cutting Edge Issues in Polymyositis , 2011, Clinical reviews in allergy & immunology.

[4]  L. Chung,et al.  The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. , 2011, Journal of the American Academy of Dermatology.

[5]  N. McHugh,et al.  Novel autoantibodies and clinical phenotypes in adult and juvenile myositis , 2011, Arthritis research & therapy.

[6]  L. Pachman,et al.  Autoantibody to PL-12 (Anti-Alanyl-tRNA Synthetase) in an African American Girl with Juvenile Dermatomyositis and Resolution of Interstitial Lung Disease , 2011, The Journal of Rheumatology.

[7]  L. Pachman,et al.  Serum Neopterin Levels as a Diagnostic Marker of Hemophagocytic Lymphohistiocytosis Syndrome , 2011, Clinical and Vaccine Immunology.

[8]  I. Sjaastad,et al.  Pulmonary outcome in juvenile dermatomyositis: a case-control study , 2010, Annals of the rheumatic diseases.

[9]  C. Oddis,et al.  Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? , 2010, Chest.

[10]  I. Lundberg,et al.  Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls , 2010, Current opinion in rheumatology.

[11]  C. Oddis,et al.  Pulmonary manifestations of the idiopathic inflammatory myopathies. , 2010, Clinics in chest medicine.

[12]  L. Taylor,et al.  Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations. , 2010, Archives of dermatology.

[13]  O. Ishikawa,et al.  Fatal interstitial pneumonia in juvenile dermatomyositis. , 2010, European journal of dermatology : EJD.

[14]  L. Wedderburn,et al.  Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. , 2009, Best practice & research. Clinical rheumatology.

[15]  N. McHugh,et al.  Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. , 2009, Rheumatology.

[16]  L. Rönnblom,et al.  S.5. Concordance of Serologic Data in Juvenile Dermatomyositis: Interferon-Alpha Induction and Activity, and Detectable Levels of Anti-Ro and Anti-La Autoantibodies , 2009 .

[17]  I. Targoff.  Autoantibodies and their significance in myositis , 2008, Current rheumatology reports.

[18]  L. Jorfeldt,et al.  Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. , 2008, Arthritis and rheumatism.

[19]  Michel Fischbach,et al.  The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. , 2008, Arthritis and rheumatism.

[20]  M. Gugger,et al.  Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus , 2008, European Respiratory Journal.

[21]  L. Wedderburn,et al.  Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. , 2007, Rheumatology.

[22]  W. Ollier,et al.  HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap. , 2007, Rheumatology.

[23]  T. Oh-ishi,et al.  Juvenile dermatomyositis: clinical characteristics and the relatively high risk of interstitial lung disease , 2007, Modern rheumatology.

[24]  L. Rider.  The heterogeneity of juvenile myositis. , 2007, Autoimmunity reviews.

[25]  Chun-Ying Wu,et al.  Predicting factors of interstitial lung disease in dermatomyositis and polymyositis. , 2007, Acta dermato-venereologica.

[26]  I. Targoff,et al.  A novel autoantibody to a 155-kd protein is associated with dermatomyositis. , 2006, Arthritis and rheumatism.

[27]  A. Dyer,et al.  Duration of illness is an important variable for untreated children with juvenile dermatomyositis. , 2006, The Journal of pediatrics.

[28]  J. Vencovský,et al.  Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2β antigen , 2006 .

[29]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.

[30]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[31]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[32]  B. Hellmich,et al.  Interstitial lung disease in polymyositis and dermatomyositis , 2005, Current rheumatology reports.

[33]  R. Bode,et al.  Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. , 2003, Arthritis and rheumatism.

[34]  Y. Takahashi,et al.  Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A. , 2002, Rheumatology.

[35]  E. Hachulla,et al.  Interstitial lung disease in polymyositis and dermatomyositis. , 2002, Arthritis and rheumatism.

[36]  M. Pistolesi,et al.  Pulmonary involvement in juvenile dermatomyositis: a two-year longitudinal study. , 2001, Rheumatology.

[37]  L. Pachman,et al.  Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. , 1999, Arthritis and rheumatism.

[38]  E. Silverman,et al.  Clinical significance of specific autoantibodies in juvenile dermatomyositis. , 1996, The Journal of rheumatology.

[39]  S. Nakajima,et al.  Elevated local production of neopterin from alveolar macrophages in patients with internal lung diseases. , 1996, General pharmacology.

[40]  M. Wener,et al.  A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children. , 1994, Arthritis and rheumatism.

[41]  A. Bohan.  History and classification of polymyositis and dermatomyositis. , 1988, Clinics in dermatology.

[42]  L. Pachman,et al.  Juvenile dermatomyositis: a clinical and immunologic study. , 1980, The Journal of pediatrics.

[43]  D. Lane,et al.  Dermatomyositis with parenchymal lung involvement. , 1972, British medical journal.